ES2094763T3 - Complejos y quelatos de azitromicina como agentes anti-ulcerosos. - Google Patents

Complejos y quelatos de azitromicina como agentes anti-ulcerosos.

Info

Publication number
ES2094763T3
ES2094763T3 ES91103336T ES91103336T ES2094763T3 ES 2094763 T3 ES2094763 T3 ES 2094763T3 ES 91103336 T ES91103336 T ES 91103336T ES 91103336 T ES91103336 T ES 91103336T ES 2094763 T3 ES2094763 T3 ES 2094763T3
Authority
ES
Spain
Prior art keywords
chelates
ulcerous
agents
azithromycin
complexes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91103336T
Other languages
English (en)
Spanish (es)
Inventor
Slobodan Djokic
Zlatko Vajtner
Hrvoje Krnjevic
Nevenka Lopotar
Lidija Kolacny-Babic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pliva Farmaceutika dd
Original Assignee
Pliva Farmaceutska Kemijska Prehrambena I Kozmeticka Industrija dd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Farmaceutska Kemijska Prehrambena I Kozmeticka Industrija dd filed Critical Pliva Farmaceutska Kemijska Prehrambena I Kozmeticka Industrija dd
Application granted granted Critical
Publication of ES2094763T3 publication Critical patent/ES2094763T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00—Compounds containing boron, silicon or a metal, e.g. chelates or vitamin B12
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ES91103336T 1990-03-07 1991-03-05 Complejos y quelatos de azitromicina como agentes anti-ulcerosos. Expired - Lifetime ES2094763T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
YU45590A YU45590A (sh) 1990-03-07 1990-03-07 Novi kompleksi odnosno helati antibiotika s dvovalentnim i/ili trovalentnim metalima i postupci za njihovo dobijanje

Publications (1)

Publication Number Publication Date
ES2094763T3 true ES2094763T3 (es) 1997-02-01

Family

ID=25550003

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91103336T Expired - Lifetime ES2094763T3 (es) 1990-03-07 1991-03-05 Complejos y quelatos de azitromicina como agentes anti-ulcerosos.

Country Status (20)

Country Link
US (1) US5498699A (enExample)
EP (1) EP0445743B1 (enExample)
JP (1) JP2731636B2 (enExample)
CN (2) CN1041166C (enExample)
AT (1) ATE143266T1 (enExample)
BG (1) BG61230B1 (enExample)
CA (1) CA2037663C (enExample)
CZ (1) CZ280181B6 (enExample)
DE (1) DE69122282T2 (enExample)
DK (1) DK0445743T3 (enExample)
ES (1) ES2094763T3 (enExample)
GR (1) GR3021947T3 (enExample)
HR (1) HRP940256B1 (enExample)
HU (2) HU209455B (enExample)
PL (1) PL166279B1 (enExample)
RO (1) RO107660B1 (enExample)
RU (2) RU2039060C1 (enExample)
SI (1) SI9010455B (enExample)
SK (1) SK279278B6 (enExample)
YU (1) YU45590A (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2064634C (en) * 1991-04-04 1998-08-04 James V. Heck 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
GB9120131D0 (en) * 1991-09-20 1991-11-06 Glaxo Group Ltd Medicaments
TW271400B (enExample) * 1992-07-30 1996-03-01 Pfizer
GB9501560D0 (en) * 1995-01-26 1995-03-15 Nycomed Imaging As Contrast agents
JPH10512877A (ja) * 1995-01-26 1998-12-08 ニコムド イメージング エイ／エス ビスマス化合物
US5900410A (en) * 1996-08-27 1999-05-04 Hartmann; John F. Monotherapy of peptic ulcers and gastritis
US6861411B1 (en) 1997-12-02 2005-03-01 Pfizer, Inc. Method of treating eye infections with azithromycin
US6239113B1 (en) 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
US7056893B2 (en) 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
HRP20010301A2 (en) * 2001-04-27 2001-12-31 Pliva D D New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases
SI1390377T1 (sl) 2001-05-22 2006-06-30 Pfizer Prod Inc Nova kristalna oblika azitromicina
CA2458135A1 (en) * 2001-08-21 2003-03-06 Pfizer Products Inc. Single dose azithromycin for treating respiratory infections
RU2283116C2 (ru) * 2002-05-27 2006-09-10 Курский государственный медицинский университет Способ увеличения выживаемости изолированного кожного лоскута "на ножке" у животных с пониженным антиоксидантным фоном
US7468428B2 (en) 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US20060046970A1 (en) * 2004-08-31 2006-03-02 Insite Vision Incorporated Topical otic compositions and methods of topical treatment of prevention of otic infections
AU2005299294B2 (en) * 2004-10-25 2012-06-07 Paratek Pharmaceuticals, Inc. 4-aminotetracyclines and methods of use thereof
WO2008045507A2 (en) 2006-10-11 2008-04-17 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of bacillus anthracis infections
CN104892694A (zh) * 2015-05-24 2015-09-09 广西师范学院 蔗糖硫酸酯铜类化合物及其制作方法和用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862225A (en) * 1961-08-18 1975-01-21 Pfizer D-ring substituted tetracyclines
US3622627A (en) * 1967-09-13 1971-11-23 Pfizer 4-dedimethylaminatetracycline and 5a, 6-anhydro derivatives thereof
HU167946B (enExample) * 1973-04-16 1976-01-28
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
EP0222834A4 (en) * 1985-04-18 1989-10-04 Borody Thomas J Treatment of non-ulcer dyspepsia with bismuth salts.
DE3686836T2 (de) * 1985-06-13 1993-03-04 Marshall Barry James Zusammensetzungen zur behandlung von magen-darmstoerungen.
IT1200774B (it) * 1985-10-10 1989-01-27 Pierrel Spa Procedimento di sentisi dell'amikacina
SI8611592A8 (en) * 1986-09-12 1995-04-30 Pliva Pharm & Chem Works Process for preparing complexes of N-methyl-11-aza-10-deoxo-10-dihydroeritromicine A and 11-aza-10-deoxo-10-dihydroeritromicine A with metals
HU198913B (en) * 1987-09-03 1989-12-28 Pliva Pharm & Chem Works Process for producing 10-dihydro-10-deoxo-11-aza-erythronolide a-derivatives and pharmaceutical compositions containing them as active components
DE3887353T2 (de) * 1987-10-12 1994-05-05 Capability Services Pty Ltd Behandlungsverfahren für magen-darm-krankheiten.
US5246708A (en) * 1987-10-28 1993-09-21 Pro-Neuron, Inc. Methods for promoting wound healing with deoxyribonucleosides
EP0391005B1 (en) * 1989-04-03 1991-10-16 Ranbaxy Laboratories, Ltd. Process for the production of alpha-6-deoxytetracyclines
US5348946A (en) * 1991-02-28 1994-09-20 Biochem Immunosystems, Inc. Heteroanthracycline antitumor analogs
MA28714B1 (fr) * 2005-12-15 2007-07-02 Green Technlology Sarl Une arabinogalactane proteine ayant la propriete d'absorber les graisses et le procede d'obtention de cette arabinogalactane proteine

Also Published As

Publication number Publication date
BG61230B1 (bg) 1997-03-31
DE69122282D1 (de) 1996-10-31
US5498699A (en) 1996-03-12
HRP940256A2 (en) 1997-06-30
CN1041166C (zh) 1998-12-16
SK279278B6 (sk) 1998-09-09
CA2037663C (en) 1999-01-19
DE69122282T2 (de) 1997-04-24
RU2039061C1 (ru) 1995-07-09
CN1054534A (zh) 1991-09-18
HUT56849A (en) 1991-10-28
BG93995A (bg) 1993-12-24
RO107660B1 (ro) 1993-12-30
JP2731636B2 (ja) 1998-03-25
HU211475A9 (en) 1995-11-28
JPH06184186A (ja) 1994-07-05
HRP940256B1 (en) 1998-10-31
CN1168891A (zh) 1997-12-31
CN1051560C (zh) 2000-04-19
SI9010455B (sl) 2000-04-30
YU45590A (sh) 1992-07-20
CA2037663A1 (en) 1991-09-08
ATE143266T1 (de) 1996-10-15
PL166279B1 (pl) 1995-04-28
EP0445743A3 (en) 1992-10-07
RU2039060C1 (ru) 1995-07-09
HU910740D0 (en) 1991-09-30
CS9100587A2 (en) 1991-10-15
EP0445743A2 (en) 1991-09-11
DK0445743T3 (enExample) 1997-02-17
SI9010455A (en) 1997-08-31
HU209455B (en) 1994-06-28
EP0445743B1 (en) 1996-09-25
CZ280181B6 (cs) 1995-11-15
GR3021947T3 (en) 1997-03-31

Similar Documents

Publication Publication Date Title
ES2094763T3 (es) Complejos y quelatos de azitromicina como agentes anti-ulcerosos.
IT7830518A0 (it) Autosmerigliante. meccanismo di valvola
SE7804191L (sv) Slidventil
ES230826Y (es) Diente amovible para utiles de excavacion o similares.
IT7824384A0 (it) Complessi abrasivi.
NL7802655A (nl) Keramiek-metaal samenstel.
NL7808410A (nl) Mengventiel.
NL7713476A (nl) Omkeerventiel.
NO800967L (no) Antibakterielle antitumor midler.
ES472284A1 (es) Procedimiento para la preparacion de 6-deoxineamina
BE872916A (fr) Antibiotique de la famille des fortimicines
NL186340C (nl) Enkelgreeps-mengkraan.
NL182428B (nl) Eengreepsmengkraan.
DE2860302D1 (de) Electromagnetic non-return valve
AT372832B (de) Baukastensystem zur erstellung von baenken, tischen od. dgl.
ES467189A1 (es) Un procedimiento para la preparacion de nuevas pirroloquino-xalinonas y pirrolobenzodiazepinonas
IT1098561B (it) Valvola di intercettazione di sicurezza elettromagnetica,ad azione diretta
AT371910B (de) Brenner, insbesondere fuer rechauds
IT8020365A0 (it) Veicolo da lavoro.
NL7804473A (nl) Motorreduktor.
AT361657B (de) Kippsicherung, auszugssperre od.dgl.
IT7819197A0 (it) Componenti per valvole di nonritorno per vuoto.
IT7819545A0 (it) Cilindro di serratura.
IT8024040A0 (it) 1-ramificato-alchil-3-(2-alogenoetil)-3-nitrosouree come agenti antitumorali.
AR211064A1 (es) Conjunto de piezas modulares tridimensionales, para la construccion de edificios.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 445743

Country of ref document: ES